诺奖!立法!中医药国际化正是时机?

2015-12-21 佚名 新康界

12月15日,在广东中医药发展座谈会上,广东省中医药管理局局长徐庆锋指出,要借助这个良好的契机进一步推动中医药国际化进程。广药白云山还设立了“中医药国际化发展基金”,投入2亿元支持旗下中药产品的境外注册、国际市场开拓和国际化合作等工作。 | 中药的国际“身份证”不易拿 中医药国际化一直是中医药产业的宏伟目标之一,早在几百年前,传统中药就曾随着海上丝绸之路走向了全世界。清朝初年,世界

12月15日,在广东中医药发展座谈会上,广东省中医药管理局局长徐庆锋指出,要借助这个良好的契机进一步推动中医药国际化进程。广药白云山还设立了“中医药国际化发展基金”,投入2亿元支持旗下中药产品的境外注册、国际市场开拓和国际化合作等工作。

| 中药的国际“身份证”不易拿

中医药国际化一直是中医药产业的宏伟目标之一,早在几百年前,传统中药就曾随着海上丝绸之路走向了全世界。清朝初年,世界上最长寿的药厂陈李济首创的蜡丸工艺,就是为了满足海外贸易需求。

然而,西医已经成为当今世界的主流医学体系,传统医药在国际上处境尴尬:全球目前仅有澳大利亚在2000年时通过了《中医药法》,以立法的形式确认了中医药的医疗保健地位。也有数个国家宣布认可中医医疗行为,或将中医药纳入医疗健康体系。

在中药方面,中成药在进入欧美主流市场依然困难重重:至今只有地奥心血康成功在荷兰注册上市,获得欧盟成员国市场通行证;天士力复方丹参滴丸、以岭的连花清瘟胶囊、绿叶的血脂康等正在FDA新药注册过程中。

可见,中成药想要获得国际主流市场认可,真正国际化,还有很多事情可做。至于屠呦呦凭青蒿素获诺贝尔奖的确离不开中医药,可不要忘记,虽然青蒿素源自中医药——无论是提取它的原材料,还是提取的方法,均是从中医药典籍中获得提示与灵感,但它实际上是化学药。国际主流市场对它的认可是没有文化障碍的。

而传统的中成药,如果想要重复青蒿素的道路,首先需要做的恐怕是放弃“中成药”的身份,从那些临床上的确使用有效的药物中,提取活性成份,甚至进行改构,再按化学药的注册流程进行临床前研究,和1、2、3期临床试验,最终获得上市资格。目前也有一些企业正在做这样的尝试。

如果不走这条路,那么通过欧美主流市场的药品注册,获得国际身份,也是一条路。其中,目前欧盟这边的路可能还相对易走,毕竟在欧盟《传统植物药(草药)注册程序指令》中有具有悠久应用史的药品,可以免做临床试验。而在FDA注册,则是需要进行1、2、3期临床试验。再者,欧盟这边已有成功案例在前,而FDA则到目前为止依然没有一个成功注册的中成药,巨大的投入很可能只能凭着“让世界认可中药”的情怀。

| 学术国际化:“通用语言”+科研合作

如果中成药并不以国际主流市场药品注册为目的,仅是希望把中药的研究成果带到国际舞台上,让学术界了解并认可,那么,循证医学研究则是“通用语言”。

目前,一些有实力的中药企业也开始与临床合作,开展多中心循证医学研究,甚至有些研究结果在国际学术舞台上亮相。

此外,现在正是中医药学术国际化的时候,广东省中医院名誉院长、广东省中医药学会会长吕玉波就直言,屠呦呦获得诺贝尔奖,也推动了广东省中医院与瑞典一流高校一流专家的合作,这当中即有医方面的合作,也有药方面的合作。“让世界上最好的科学家参与到中医药的研究来,有利于中医药的发展,有利于中医药走向世界。”他表示。

| 国际化的基础:中国人先认可

如果说中医药国际化是被寄予厚望的美好未来,那么现实则是要先让中医药在国内获得更多的认可。

如今,中药行业面临巨大的挑战:在新一轮的招标采购中,中药被采用的数量正在下降。以福建省招标为例,2015年中成药目录从2014年的1853种下降到920种,减少了一半;同时,中药保护品种的数据也在逐年减少,2012年时尚有913个,至2013年只剩下504个,2014年时更少,仅316个。

正是这样严峻的情况,更要求中药行业要做得更好。广东省政协常委、广州中医药大学教授徐志伟表示:“我们要做好名优产品的二次开发”,把药做得更精确些,提纯更高,更符合群众要求,使药物更加安全、有效。

有消息称在化学药仿制药一致性评价后,中药的真实临床条件下的再评价工作也将推广。前FDA审评官龚兆龙指出:“已上市的中成药做真实临床条件下的再评价对证实临床价值非常有帮助,可以良币驱劣币。”

中药无论是走哪条路,最终不可回避的一定是“临床价值”4个字,只有对患者真正有用的中药才是有价值的中药。

因而,中药企业真正想要长存市场并获得更长远的发展,对药品品质的追求就是这一切的基础与核心——回看那些历史悠久的中药企业,他们至少在这一点是共通的。正如前面提到的陈李济,历经415年,时代变迁,它依然屹立,除了“蜡丸工艺”和坚持“同心济世”这个从创始之初就带着的文化基因外,还有其对中药炮制技术的追求和坚持——即便在当时的科技条件下,经他们炮制的中药材依然能百年不坏,成就“百年陈皮”的美名,而以此为君药的陈李济咳喘顺丸如今仍能远销国际。 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2016-01-17 Homburg
  2. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2016-01-13 medsic

    不懂,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2016-01-13 medsic

    不懂,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2016-01-13 medsic

    嗯,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2016-01-13 medsic

    感谢分享~~

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2016-01-13 medsic

    感谢分享~~

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2015-12-26 hixiaoluo

    早就该这样了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2015-12-26 hixiaoluo

    值得看,好好收藏

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2015-12-25 忠诚向上

    发展

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1915628, encodeId=2e941915628a1, content=<a href='/topic/show?id=0d15410e5d2' target=_blank style='color:#2F92EE;'>#国际化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41075, encryptionId=0d15410e5d2, topicName=国际化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 17 21:18:00 CST 2016, time=2016-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56707, encodeId=946e56e07c2, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56708, encodeId=808456e0884, content=不懂,, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56709, encodeId=07b056e0926, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56710, encodeId=67b156e1049, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56711, encodeId=ae9b56e114c, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:05:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48175, encodeId=6150481e585, content=早就该这样了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:44:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48174, encodeId=7adf481e424, content=值得看,好好收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 15:43:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47719, encodeId=af5e4e7193b, content=发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Fri Dec 25 15:36:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47214, encodeId=16524e21420, content=中药, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Wed Dec 23 10:11:00 CST 2015, time=2015-12-23, status=1, ipAttribution=)]
    2015-12-23 xiaotaiyang1

    中药

    0

相关资讯

80后的华人学霸张锋:开创基因编辑时代,明天他会得诺贝尔奖吗?

题记——在中国度过童年时光,高中时便荣获 Intel 大奖。刚过而立之年的他,以发现CRISPR/Cas9里程碑式成果载入生物学史册。他是张锋、华人生物学界最耀眼的新星,也是诺贝尔奖的大热门。明天凌晨,他会收到来自斯德哥尔摩的电话吗? 先看看他简单的履历吧: 1983年出生中国石家庄 2004年毕业于哈佛大学化学物理专业

屠呦呦获得诺贝尔奖 被称为"三无"科学家

昨天下午,屠呦呦获得诺贝尔生理学或医学奖的消息传出后不久,一则“热烈祝贺北大校友屠呦呦获诺贝尔生理医学奖”的消息就迅速在“北京大学”“北京大学招生办”等多个北大官方微信公众号传播。消息称,1951年,屠呦呦考入北京大学医学院(现为北京大学医学部),选择药物学系生药学专业为第一志愿。早在2011年9月,屠呦呦获得被誉为诺贝尔奖“风向标”的拉斯克奖之前,北京大学生命科学学院前任院长饶毅就高度评价过

2015年诺贝尔奖揭晓时间已确定

据诺贝尔奖官方网站2015年9月27日报道,2015年诺贝尔奖的揭晓时间已经确定(以下时间均为欧洲中部时间):生理学或医学奖揭晓时间最早为:2015年10月5日上午11:30物理学奖揭晓时间最早为:2015年10月6日上午11:45化学学奖揭晓时间最早为:2015年10月7日上午11:45和平奖揭晓时间最早为:2015年10月9日上午11:00经济学奖揭晓时间最早为:2015年10月12日下午1:

王晓东谈诺奖:我们来了,我们还会经常再来

王晓东(北京生命科学研究所所长) 转载自饶毅、鲁白、谢宇主编的微信号:知识分子(The-Intellectual)。 人活着,最困惑的无外乎“我从哪里来”、“要到哪里去”两大问题。有宗教情结的朋友这时会指出,答案在他们那里、而不在科学中。因为科学有局限。 而我则会说:“其实,我们科学界也有实实在在的答案。我们不光能对这两个问题给出解释,还知道你来这儿干什么。”答案就在我们现代生物学的

诺贝尔医学奖获奖人是怎样评选出来的?----浅析屠教授荣获诺奖

中国女科学家屠呦呦以青蒿素在抗疟药物上的创新研究,荣获2015年诺贝尔医学奖。这是中国大陆本土科学家首次获得诺贝尔医学奖。屠呦呦教授成为获得诺贝尔生理或医学奖的第十二位女性科学家。诺贝尔医学奖获奖人是怎么评选出来的? (一) 诺贝尔奖提名和评审程序 诺贝尔奖始于1901年,已有一百多年的历史记录。诺贝尔奖委员会对整个提名(包括提名人和被提名人)及评审过程严格保密(保密期为

2015年医学和生理学诺贝尔奖花落谁手?

一年一度的诺贝尔奖马上就要到了。最近SCI肯定会有引用率预测,但是准确性并不十分理想。诺贝尔奖的推荐更多是依靠同行推荐,那么热门领域和成熟领域被推荐的可能性比较大,引用多只能是大众化领域,干细胞和肿瘤研究显然是引用最多的领域,但不一定是颠覆性、概念性和革命性的研究。就医学与生理学奖而言,2015年度哪些技术可能获奖?抢先一步,也来猜一猜凑个热闹吧。一、基因编辑这个领域显然是呼声最热的领域。按照诺贝